SLACK Incorporated launches HCV Next

March 18, 2014

THOROFARE, N.J. — SLACK Incorporated, publisher of Infectious Disease News, has launched HCV Next, the first multidisciplinary publication exclusively focused on hepatitis C.

Published six times annually, HCV Next will reach more than 10,000 physicians who actively diagnose and treat hepatitis C virus.

Continue reading article here …..

---

• About Us
• Advertising Information
• Contact the Editor
• Editorial Policy and Philosophy
• Meet the Editorial Board
• Mission Statement
• Order Article Reprints
• Subscribe
• Renew

-------------------------------------------------------------

The following articles appeared in the print edition of HCV NEXT.

Cover Stories

• The Promise of New HCV Therapies

Editorial

• An invaluable resource for hepatitis C specialists has arrived

Trend Watch

• Current HCV Therapies May Not Benefit Older Patients
• HCV Prevalence Among Hispanics Varies by Group
• HCV Underdocumented on Death Certificates
• Investigational Combination Treatment Yields High SVR Rate
• Lymphocyte Count Linked to Infection Risk During Interferon Treatment
• Vitamin D Levels Fail to Predict Treatment Outcome

Pediatric HCV

• More Than Two Roads in the Yellow Wood for the Pediatric HCV Patient Kathleen B. Schwarz, MD

Feature

• Recommendations for a Revolution

HCV Rx

• Sofosbuvir: A Novel Polymerase Inhibitor Leah Molloy, PharmD

Patient Profile

• The Challenge of Pregnancy in HCV Infection Manoj Kumar, MD; Alia Hasham, MD; Abha Rani, MD; Andrew H. Talal, MD, MPH

The Take Home

• The Liver Meeting 2013

5 Questions

• A conversation with Eric J. Lawitz, MD

Source